<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.travelmedicinejournal.com//inpress?rss=yes"><title>Travel Medicine and Infectious Disease - Articles in Press</title><description>Travel Medicine and Infectious Disease RSS feed: Articles in Press.    The journal will publish original papers and invited reviews covering all aspects of travel medicine and infectious disease. These will 
include the epidemiology and surveillance of travel-related infectious disease, vaccine-preventable disease, illness in returning travellers, 
aviation medicine including psychological aspects, environmental hazards of travel, practical clinical issues for travellers, tropical 
medicine and tropical skin disease and general aspects of travel medicine and infectious disease. 
 
The journal will also bring together 
knowledge from different specialties involved in the research and clinical practice of travel medicine and infectious disease. 
 
The 
journal will publish topical leading academic reviews and opinion papers, original articles and case reports as well as a correspondence 
section.   </description><link>http://www.travelmedicinejournal.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Elsevier Ltd. All rights reserved. </dc:rights><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:issn>1477-8939</prism:issn><prism:publicationDate>2012-01-24</prism:publicationDate><prism:copyright> © 2012 Elsevier Ltd. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893912000026/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001281/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001268/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001256/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS147789391100127X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001293/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001220/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893911001086/abstract?rss=yes"/><rdf:li rdf:resource="http://www.travelmedicinejournal.com/article/PIIS1477893908000100/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893912000026/abstract?rss=yes"><title>Hepatitis A seroprevalence in children and adolescents aged 1–18 years among a low socioeconomic population in Izmir, Turkey - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893912000026/abstract?rss=yes</link><description>Summary: The age-specific prevalence of hepatitis A virus (HAV) infection and risk factors were evaluated in a low socioeconomic population in Izmir.Children and adolescents 1–18 years of age admitted to the outpatient clinics for follow-up visits, or healthy children between April–December 2009 were investigated for anti-HAV antibodies by a cross-sectional study. A questionnaire on sociodemographic and hygiene information was obtained from the parents. All unvaccinated children against HAV were grouped according to their age. Seven hundred and twenty-nine children were enrolled in the study.Total HAV IgG seropositivity was 29.5% while age related values were as follows: 1–2 years, 21.4%; 2.1–5 years, 15.1%; 5.1–8 years, 20.1%; 8.1–11 years, 32.6%; 11.1–14 years, 44.3% and 14.1–18 years, 52.4%. The presence of anti-HAV IgG was associated significantly with low family income and lack of education of parents and living in a crowded family. HAV infection was endemic in a population of children living in Izmir. Anti-HAV vaccination should be considered for preschool children because teenagers are at risk of infection in this region.</description><dc:title>Hepatitis A seroprevalence in children and adolescents aged 1–18 years among a low socioeconomic population in Izmir, Turkey - Corrected Proof</dc:title><dc:creator>Oya Halicioglu, Sezin A. Akman, Bengu Tatar, Ruya Atesli, Sukran Kose</dc:creator><dc:identifier>10.1016/j.tmaid.2012.01.001</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2012)</dc:source><dc:date>2012-01-24</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2012-01-24</prism:publicationDate></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001281/abstract?rss=yes"><title>A model-based tool to predict the propagation of infectious disease via airports - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001281/abstract?rss=yes</link><description>Summary: Epidemics of novel or re-emerging infectious diseases have quickly spread globally via air travel, as highlighted by pandemic H1N1 influenza in 2009 (pH1N1). Federal, state, and local public health responders must be able to plan for and respond to these events at aviation points of entry.The emergence of a novel influenza virus and its spread to the United States were simulated for February 2009 from 55 international metropolitan areas using three basic reproduction numbers (R0): 1.53, 1.70, and 1.90. Empirical data from the pH1N1 virus were used to validate our SEIR model.Time to entry to the U.S. during the early stages of a prototypical novel communicable disease was predicted based on the aviation network patterns and the epidemiology of the disease. For example, approximately 96% of origins (R0 of 1.53) propagated a disease into the U.S. in under 75 days, 90% of these origins propagated a disease in under 50 days. An R0 of 1.53 reproduced the pH1NI observations.The ability to anticipate the rate and location of disease introduction into the U.S. provides greater opportunity to plan responses based on the scenario as it is unfolding. This simulation tool can aid public health officials to assess risk and leverage resources efficiently.</description><dc:title>A model-based tool to predict the propagation of infectious disease via airports - Corrected Proof</dc:title><dc:creator>Grace M. Hwang, Paula J. Mahoney, John H. James, Gene C. Lin, Andre D. Berro, Meredith A. Keybl, D. Michael Goedecke, Jennifer J. Mathieu, Todd Wilson</dc:creator><dc:identifier>10.1016/j.tmaid.2011.12.003</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2012)</dc:source><dc:date>2012-01-16</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2012-01-16</prism:publicationDate></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001268/abstract?rss=yes"><title>Rubella contact tracing associated with air travel - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001268/abstract?rss=yes</link><description>Summary: This report reviews U.S. guidelines for the identification of persons exposed to rubella during air travel. In response to an individual with rubella who traveled on multiple flights, CDC conducted an airline contact investigation that was expanded beyond customary protocol to assess if current operating procedures are adequate. Of 250 potentially exposed airline passengers, 215 (86%) were contacted and none developed a rubella-like rash, arguing against the need to notify passengers beyond the standard protocol in most cases.</description><dc:title>Rubella contact tracing associated with air travel - Corrected Proof</dc:title><dc:creator>Curi Kim, Pollyanna Chavez, Abbi Pierce, Andrew Murray, Molly Sander, Cynthia Kenyon, Ruta Sharangpani, Emily Abernathy, Joseph Icenogle, Preeta K. Kutty, Susan B. Redd, Kathleen Gallagher, John Neatherlin, Karen Marienau</dc:creator><dc:identifier>10.1016/j.tmaid.2011.11.003</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2012)</dc:source><dc:date>2012-01-04</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2012-01-04</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001256/abstract?rss=yes"><title>Peritoneal tuberculosis in Qatar: A five-year hospital-based study from 2005 to 2009 - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001256/abstract?rss=yes</link><description>Summary: There is limited information about peritoneal tuberculosis in Qatar. This retrospective study aimed to review our experience with peritoneal tuberculosis in patients admitted to Hamad general hospital over a period of 5 years, from 2005 to 2009, with emphasis on presentation, investigation, diagnosis and therapeutic outcome. Fifty-four patients with peritoneal tuberculosis identified during the study period were included. The mean age of them was 31.85 years and 96.3% (52/54) of them were non-Qataris with male predominance. The main symptoms and signs at the time of presentation were abdominal pain and ascites respectively. Underlying diseases were described in 24% (13/54) and history of contact with tuberculous cases was present in 31.5% (17/54) of patients. Tuberculin test was positive in 66.7% (36/54). The ascitic fluid smear showed acid fast bacilli in 2% (1/53), and culture was positive in 39.6% (21/53) of cases. Laparoscopically obtained peritoneal biopsy showed caseating granulomas in 93% (40/43) and mycobacteria were identified by acid fast staining and culture in 58.5% (24/41) and 98% (40/41) of the tested specimens respectively. Most of the patients (84%; 37/44) who had completed their therapy in Qatar improved with antituberculosis therapy, and only one patient died. In conclusion, the clinical features and the imaging findings of the disease were non-specific. A high index of suspicion is essential for early diagnosis. Culture of ascitic fluid delayed the diagnosis in clinically suspected cases, whereas laparoscopically guided peritoneal biopsy provided rapid and correct diagnosis. A Six-month course with antituberculous therapy was effective and improved the outcome.</description><dc:title>Peritoneal tuberculosis in Qatar: A five-year hospital-based study from 2005 to 2009 - Corrected Proof</dc:title><dc:creator>Fahmi Yousef Khan, Ahmed Mustafa AL-Muzrakchi, Mamoon M. Elbedawi, Attor Ahmed AL-Muzrakchi, Abdulhakeem Al Tabeb</dc:creator><dc:identifier>10.1016/j.tmaid.2011.12.001</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2012)</dc:source><dc:date>2012-01-03</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2012-01-03</prism:publicationDate></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS147789391100127X/abstract?rss=yes"><title>Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS147789391100127X/abstract?rss=yes</link><description>This book, as stated by the Editors, is concerned primarily with the risk of different diseases in relation to geography. In addition to a few excellent general introductory chapters, the book addresses geographical disease profiles, incubation periods of infections and presenting symptoms, according to the United Nations world regions. As such, the book succeeds extremely well and the Editors are to be congratulated on a comprehensive and very readable text, free of the usual clichés. There are many useful and informative tables and the references are generally well selected.</description><dc:title>Corrected Proof</dc:title><dc:creator>Jane N. Zuckerman</dc:creator><dc:identifier>10.1016/j.tmaid.2011.12.002</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2011)</dc:source><dc:date>2011-12-29</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2011-12-29</prism:publicationDate><prism:section>BOOK REVIEW</prism:section></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001293/abstract?rss=yes"><title>Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001293/abstract?rss=yes</link><description>Much has been written in the professional literature on infectious diseases in children, but little is available to the public apart from sensation-hungry journals, the world-wide web (the internet) – often unreliable – or more likely fictitious information from movies, television and chat shows. Welcome, therefore, at long last, a much needed book on infectious diseases which bursts with comprehensive, accurate information and sensible unpretentious practical advice for lay parents.</description><dc:title>Corrected Proof</dc:title><dc:creator>Jane N. Zuckerman</dc:creator><dc:identifier>10.1016/j.tmaid.2011.12.004</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2011)</dc:source><dc:date>2011-12-29</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2011-12-29</prism:publicationDate><prism:section>BOOK REVIEW</prism:section></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001220/abstract?rss=yes"><title>The prevalance of respiratory viruses among healthcare workers serving pilgrims in Makkah during the 2009 influenza A (H1N1) pandemic - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001220/abstract?rss=yes</link><description>Summary: Despite the high risk of acquiring respiratory infections, healthcare workers who treat pilgrims at Hajj have not been studied in previous research on respiratory diseases during Hajj. The objective of this study was to determine the prevalence of different respiratory viruses among healthcare workers who treated pilgrims during Hajj 2009, the year of the influenza A H1N1 pandemic. A cross-sectional study was performed just before and after Hajj (25–29 November, 2009). Nasal and throat swabs were tested for 18 respiratory virus types and subtypes. A total of 184 healthcare workers were examined. Most were men (85%) with an average age of 41 years. Before the Hajj, rates of seasonal influenza vaccination were higher (51%) than rates of pandemic influenza A H1N1 vaccination (22%). After the Hajj, participants reported high rates of maintaining hand hygiene (98%), cough etiquette (89%), and wearing a face mask (90%). Among all the viruses tested, only two were detected: rhinovirus was detected in 12.6% and Coronavirus 229E in 0.6%. Rhinovirus was detected in 21% of those who had respiratory symptoms during Hajj. Influenza A (including H1N1), influenza B. respiratory syncytial virus, other coronaviruses, parainfluenza viruses, human metapneumovirus, adenovirus, and human bocavirus were not detected. The finding of high rates of rhinovirus infection corresponds to their frequent occurrence in adults. None of the participants had influenza A H1N1 2009, possibly because it was also infrequent among the 2009 pilgrims.</description><dc:title>The prevalance of respiratory viruses among healthcare workers serving pilgrims in Makkah during the 2009 influenza A (H1N1) pandemic - Corrected Proof</dc:title><dc:creator>Ziad A. Memish, Abdullah M. Assiri, Mohammed Alshehri, Raheela Hussain, Ibrahim Alomar</dc:creator><dc:identifier>10.1016/j.tmaid.2011.11.002</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2011)</dc:source><dc:date>2011-12-26</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2011-12-26</prism:publicationDate></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893911001086/abstract?rss=yes"><title>West Nile Virus (WNV) infection presenting as acute chorea - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893911001086/abstract?rss=yes</link><description>West Nile (WNV) made its first appearance in North America in 1999 in New York City. Since then, WNV has spread, establishing itself as the leading cause of arboviral encephalitis in the US. WNV belongs to the Japanese encephalitis (JE) subgroup, which includes St. Louis Encephalitis. WNV may be classified clinically into non-neuroinvasive and neuroinvasive disease. Non-neuroinvasive WNV infections present with a spectrum of symptoms, i.e., fever, headache, myalgias/arthralgias, which are often subclinical. Neuroinvasive WNV infections include meningitis, encephalitis ± acute flaccid paralysis and ranges from mild to severe cases. West Nile Encephalitis (WNE) is the most common neuroinvasive form of WNV infection and may be fatal in the elderly and immunocompromised.</description><dc:title>West Nile Virus (WNV) infection presenting as acute chorea - Corrected Proof</dc:title><dc:creator>Burke A. Cunha, Semie Kang, Joseph G. Chandrankunnel</dc:creator><dc:identifier>10.1016/j.tmaid.2011.10.002</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>CORRESPONDENCE</prism:section></item><item rdf:about="http://www.travelmedicinejournal.com/article/PIIS1477893908000100/abstract?rss=yes"><title>WITHDRAWN: CDC Health Information for International Travel 2008, M. Arguin Paul, E. Kozarsky Phyllis, Reed Christie. Elsevier Mosby, Atlanta, USA (2008) (xiv)+627pp, GBP19, Paperback, ISBN: 978-0-323-04885-9 - Corrected Proof</title><link>http://www.travelmedicinejournal.com/article/PIIS1477893908000100/abstract?rss=yes</link><description>The Publisher regrets that this article is an accidental duplication of an article that has already been published in Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2008.01.006. The duplicate article has therefore been withdrawn.</description><dc:title>WITHDRAWN: CDC Health Information for International Travel 2008, M. Arguin Paul, E. Kozarsky Phyllis, Reed Christie. Elsevier Mosby, Atlanta, USA (2008) (xiv)+627pp, GBP19, Paperback, ISBN: 978-0-323-04885-9 - Corrected Proof</dc:title><dc:creator>Peter A. Leggat</dc:creator><dc:identifier>10.1016/j.tmaid.2008.01.006</dc:identifier><dc:source>Travel Medicine and Infectious Disease (2008)</dc:source><dc:date>2008-03-10</dc:date><prism:publicationName>Travel Medicine and Infectious Disease</prism:publicationName><prism:publicationDate>2008-03-10</prism:publicationDate></item></rdf:RDF>
